• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug approvals

FDA
Pharma

FDA clears Pfizer spinout SpringWorks' rare disease drug Ogsiveo

Besides this approval, SpringWorks sees potential for Ogsiveo to boost the efficacy of BCMA-targeted multiple myeloma therapies.
Angus Liu Nov 27, 2023 6:18pm
BMS

FDA clears Bristol Myers cancer drug from Turning Point buy

Nov 16, 2023 11:10am
Stamp with blue ink that says FDA Approved

Coherus spurns 'heavily discounted' pricing for new PD-1 med

Oct 30, 2023 12:10pm
Lilly

Delayed FDA nod moves Lilly into crowded ulcerative colitis field

Oct 27, 2023 11:10am
GSK

FDA approves GSK's Jakafi challenger in blood cancer

Sep 15, 2023 4:16pm
Asia

Otsuka, Astellas, Exelixis and Insilico—Fierce Pharma Asia

Sep 15, 2023 9:00am

Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy